Mumbai: The mucormycosis cases are surging in the country and in a new evolution, three verified cases of avascular necrosis or dying of bone tissues after COVID-19 have been scientifically informed from Mumbai. Avascular Necrosis(AVN) could be the next crippling condition among post-COVID patients after the eruption of mucormycosis or black fungus two months back. Doctors fear that more cases of AVN are likely in the upcoming months.
As per a report in a national daily, Hinduja Hospital, Mahim, treated the three young (under 40) sufferers who developed necrosis two months after they were treated for COVID. “These patients evolved pain in their femur bone (the highest part of the thigh bone) and, since they were doctors, they recognized the indications and rushed for treatment,’’ said Dr. Sanjay Agarwala, medical director of Hinduja Hospital, Mahim, was quoted as saying by the newspaper.
The comparison between AVN and mucormycosis is the use of steroids, the only drug proven to help COVID-19 victims. Dr. Agarwala’s research paper, ‘Avascular necrosis as a part of long COVID-19’, was published on Saturday in the prestigious medical journal ‘BMJ Case Studies’. He stated the “large-scale use of life-saving corticosteroids” in COVID-19 cases will reflect in a “insurgence of AVN cases”.
Meanwhile, of the 264 victims with mucormycosis, in the government hospital in Coimbatore, 30 have lost the eye sight in one eye, a key official of the hospital said on Sunday. All those admitted had sustained endoscopy with 110 ongoing visualization surgery, the hospital Dean Dr. N Nirmala said in a release. But 30 patients with serious contamination had lost their sight in one eye, she said, adding that those who had come at an early stage were totally healed of the disease.
Also, the government has assigned an additional 2,12,540 vials of Amphotericin-B to states, Union Territories (UTs), and central institutions, Union minister Sadananda Gowda recently said. Amphotericin-B is used to treat black fungus, which injure the nose, eyes, sinuses, and sometimes even the brain.
“Additional 2,12,540 vials of #LiposomalAmphotericinB have been assigned to all the States/UTs & Central Institutions today. As yet, approximately 10 lakh vials have been distributed across the country,” Gowda had tweeted. The doctors in India are registering an alarming number of cases of mucormycosis among patients with Covid-19 and those who have recently improved.
They believe that mucormycosis may be sparked by the use of steroids, a life-saving treatment for serious and critically ill Covid-19 victims.